SENSIPAR (cinacalcet HCl)
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
AMGEN
Indication
Hypercalcemia due to primary hyperparathyroidism
Hypercalcemia due to primary hyperparathyroidism is an endocrine condition marked by elevated serum calcium concentrations resulting from the autonomous, unregulated overproduction of parathyroid hormone (PTH) by one or more abnormal parathyroid glands, most frequently a benign solitary adenoma. Read more about Hypercalcemia due to primary hyperparathyroidism
19 drugs 16 manufacturers
Drugs that treat it
Common Hypercalcemia due to primary hyperparathyroidism therapies.
CINACALCET HCL
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
CIPLA USA, INC.
CINACALCET HCL
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
SLATE RUN PHARM
CINACALCET (cinacalcet HCl)
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
Mylan Pharmaceuticals
CINACALCET (cinacalcet HCl)
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
ASCEND LABORATO
CINACALCET (cinacalcet HCl)
PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
SUN PHARMA GLOB
CINACALCET (cinacalcet HCl)
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
STRIDES PHARMA
CINACALCET HCL
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
Mylan Pharmaceuticals
CINACALCET HCL
CALCIMIMETIC, PARATHYROID CALCIUM RECEP SENSITIVITY ENHANCER·PARATHYROID CARCINOMA WITH HYPERCALCEMIA·+2
Major Pharamceuticals
Filter & compare in the drug finder →Opens the drug finder with Hypercalcemia due to primary hyperparathyroidism preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypercalcemia due to primary hyperparathyroidism is an endocrine condition marked by elevated serum calcium concentrations resulting from the autonomous, unregulated overproduction of parathyroid hormone (PTH) by one or more abnormal parathyroid glands, most frequently a benign solitary adenoma.
It primarily affects adults—most commonly postmenopausal women—and involves disrupted calcium homeostasis across the skeletal, renal, and gastrointestinal systems.
Pathophysiologically, inappropriate excess PTH stimulates osteoclastic bone resorption, increases renal tubular reabsorption of calcium, and enhances 1,25-dihydroxyvitamin D synthesis to promote intestinal calcium absorption.
Clinically, it ranges from asymptomatic hypercalcemia detected on routine blood testing to overt disease manifesting with nephrolithiasis, decreased bone mineral density, osteopenia, bone fractures, and neuromuscular or neuropsychiatric symptoms.
- nih.gov
Hypercalcemia due to primary hyperparathyroidism is an endocrine condition marked by elevated serum calcium concentrations resulting from the autonomous, unregulated overproduction of parathyroid hormone (PTH) by one or more abnormal parathyroid glands, most frequently a benign solitary adenoma It primarily affects adults—most commonly postmenopausal women—and involves disrupted calcium homeostasis across the skeletal, renal, and gastrointestinal systems Pathophysiologically, inappropriate exces...
- nih.gov
Clinically, it ranges from asymptomatic hypercalcemia detected on routine blood testing to overt disease manifesting with nephrolithiasis, decreased bone mineral density, osteopenia, bone fractures, and neuromuscular or neuropsychiatric symptoms
- nih.gov
Clinically, it ranges from asymptomatic hypercalcemia detected on routine blood testing to overt disease manifesting with nephrolithiasis, decreased bone mineral density, osteopenia, bone fractures, and neuromuscular or neuropsychiatric symptoms
Personalize your experience
Follow Hypercalcemia due to primary hyperparathyroidism and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.